Stem Cell Research
Companies announce collaboration on diabetes-focused stem cell studies
Published in Obesity and Diabetes Week, April 11th, 2005
Over the next 18 months Genzyme will conduct research to improve production and characterization of islet stem cells, and to undertake preclinical proof-of-concept studies for the transplantation of adult islet stem cells derived from donated pancreatic tissue. ViaCell will work with Genzyme and conduct complementary preclinical research. No financial terms of the agreement were announced.
ViaCell also announced the issuance of U.S. Patent No. 6,866,843 entitled, "Method of Transplanting in a Mammal and Treating Diabetes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Bardet-Biedl Syndrome
Genetic study differentiates BBS from Meckel syndrome at antenatal presentation - Gastroenterology
Lipid in the liver leads to inflammation and insulin resistance - Insulin Resistance
Inactivity is worse than obesity for risk of insulin resistance - Insulin Resistance
Researchers call for new techniques for evaluating SI during puberty - Type 2 Diabetes
PS is better than limb flow to mark insulin resistance during hyperinsulinemia - Adipose Tissue
Adrenomedullin may be a new member of adipokines - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
